Cargando…
Interferon-inducible protein 16 may be a biomarker and prognostic factor in renal cell carcinoma by bioinformatics analysis
BACKGROUND: Renal cell carcinoma (RCC) accounts for 2% to 3% of all human malignancies and is the 9th most common malignancy in Western countries. Due to the development of surgical procedures and the use of novel drugs, survival has been significantly prolonged. However, current challenges include...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793379/ https://www.ncbi.nlm.nih.gov/pubmed/33429832 http://dx.doi.org/10.1097/MD.0000000000024257 |
_version_ | 1783633977026805760 |
---|---|
author | Yu, Baozhong Zhang, Jiandong Sun, Zejia Cao, Peng Zheng, Xiang Gao, Zihao Cao, Haoyuan Zhang, Feilong Wang, Wei |
author_facet | Yu, Baozhong Zhang, Jiandong Sun, Zejia Cao, Peng Zheng, Xiang Gao, Zihao Cao, Haoyuan Zhang, Feilong Wang, Wei |
author_sort | Yu, Baozhong |
collection | PubMed |
description | BACKGROUND: Renal cell carcinoma (RCC) accounts for 2% to 3% of all human malignancies and is the 9th most common malignancy in Western countries. Due to the development of surgical procedures and the use of novel drugs, survival has been significantly prolonged. However, current challenges include how to diagnose RCC earlier and how to overcome drug resistance. Methods: We explored the relationship between the transcription level of IFI16 and clinical data in RCC through various online databases, including ONCOMINE, GEPIA, HPA, Timer and COEXPEDIA. RESULTS: In comparison with corresponding normal tissues, IFI16 mRNA expression levels were higher in kidney renal clear cell carcinoma (KIRC) and kidney renal papillary cell carcinoma (KIRP) tissues. In KIRC, the higher expression of IFI16 was associated with lower overall survival (P = .037). In KIRP, the higher expression IFI16 was associated with lower disease-free survival and overall survival (P = .037 and P = .011). In contrast, the IFI16 expression was negatively correlated with tumor purity in kidney chromophobe, KIRC and KIRP (all P < .05). In KIRC and KIRP, the expression of IFI16 was positively correlated with tumor-infiltrating immune cells (TIICs) (all P < .05), except macrophages in KIRP. In KIRC, the main TIICs were B cells, CD4(+)T cells, neutrophils, and dendritic cells, while the main TIICs in the high amplification state were macrophage (all P < .0001). Functional enrichment analysis by gene ontology and Kyoto Encyclopedia of Genes and Genomes highlighted enrichment of neutrophil degranulation, phagocytosis and vesicle-mediated transport regulation, and pathways including tuberculosis, toxoplasmosis, phagosome, leishmaniasis, and Fc gamma R-mediated. CONCLUSIONS: IFI16 is overexpressed in RCC and may be an important oncogene in the progression of kidney. In addition, IFI16 may a marker for RCC diagnosis and prognosis, which may be related to immune infiltration. |
format | Online Article Text |
id | pubmed-7793379 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-77933792021-01-11 Interferon-inducible protein 16 may be a biomarker and prognostic factor in renal cell carcinoma by bioinformatics analysis Yu, Baozhong Zhang, Jiandong Sun, Zejia Cao, Peng Zheng, Xiang Gao, Zihao Cao, Haoyuan Zhang, Feilong Wang, Wei Medicine (Baltimore) 7300 BACKGROUND: Renal cell carcinoma (RCC) accounts for 2% to 3% of all human malignancies and is the 9th most common malignancy in Western countries. Due to the development of surgical procedures and the use of novel drugs, survival has been significantly prolonged. However, current challenges include how to diagnose RCC earlier and how to overcome drug resistance. Methods: We explored the relationship between the transcription level of IFI16 and clinical data in RCC through various online databases, including ONCOMINE, GEPIA, HPA, Timer and COEXPEDIA. RESULTS: In comparison with corresponding normal tissues, IFI16 mRNA expression levels were higher in kidney renal clear cell carcinoma (KIRC) and kidney renal papillary cell carcinoma (KIRP) tissues. In KIRC, the higher expression of IFI16 was associated with lower overall survival (P = .037). In KIRP, the higher expression IFI16 was associated with lower disease-free survival and overall survival (P = .037 and P = .011). In contrast, the IFI16 expression was negatively correlated with tumor purity in kidney chromophobe, KIRC and KIRP (all P < .05). In KIRC and KIRP, the expression of IFI16 was positively correlated with tumor-infiltrating immune cells (TIICs) (all P < .05), except macrophages in KIRP. In KIRC, the main TIICs were B cells, CD4(+)T cells, neutrophils, and dendritic cells, while the main TIICs in the high amplification state were macrophage (all P < .0001). Functional enrichment analysis by gene ontology and Kyoto Encyclopedia of Genes and Genomes highlighted enrichment of neutrophil degranulation, phagocytosis and vesicle-mediated transport regulation, and pathways including tuberculosis, toxoplasmosis, phagosome, leishmaniasis, and Fc gamma R-mediated. CONCLUSIONS: IFI16 is overexpressed in RCC and may be an important oncogene in the progression of kidney. In addition, IFI16 may a marker for RCC diagnosis and prognosis, which may be related to immune infiltration. Lippincott Williams & Wilkins 2021-01-08 /pmc/articles/PMC7793379/ /pubmed/33429832 http://dx.doi.org/10.1097/MD.0000000000024257 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0 |
spellingShingle | 7300 Yu, Baozhong Zhang, Jiandong Sun, Zejia Cao, Peng Zheng, Xiang Gao, Zihao Cao, Haoyuan Zhang, Feilong Wang, Wei Interferon-inducible protein 16 may be a biomarker and prognostic factor in renal cell carcinoma by bioinformatics analysis |
title | Interferon-inducible protein 16 may be a biomarker and prognostic factor in renal cell carcinoma by bioinformatics analysis |
title_full | Interferon-inducible protein 16 may be a biomarker and prognostic factor in renal cell carcinoma by bioinformatics analysis |
title_fullStr | Interferon-inducible protein 16 may be a biomarker and prognostic factor in renal cell carcinoma by bioinformatics analysis |
title_full_unstemmed | Interferon-inducible protein 16 may be a biomarker and prognostic factor in renal cell carcinoma by bioinformatics analysis |
title_short | Interferon-inducible protein 16 may be a biomarker and prognostic factor in renal cell carcinoma by bioinformatics analysis |
title_sort | interferon-inducible protein 16 may be a biomarker and prognostic factor in renal cell carcinoma by bioinformatics analysis |
topic | 7300 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793379/ https://www.ncbi.nlm.nih.gov/pubmed/33429832 http://dx.doi.org/10.1097/MD.0000000000024257 |
work_keys_str_mv | AT yubaozhong interferoninducibleprotein16maybeabiomarkerandprognosticfactorinrenalcellcarcinomabybioinformaticsanalysis AT zhangjiandong interferoninducibleprotein16maybeabiomarkerandprognosticfactorinrenalcellcarcinomabybioinformaticsanalysis AT sunzejia interferoninducibleprotein16maybeabiomarkerandprognosticfactorinrenalcellcarcinomabybioinformaticsanalysis AT caopeng interferoninducibleprotein16maybeabiomarkerandprognosticfactorinrenalcellcarcinomabybioinformaticsanalysis AT zhengxiang interferoninducibleprotein16maybeabiomarkerandprognosticfactorinrenalcellcarcinomabybioinformaticsanalysis AT gaozihao interferoninducibleprotein16maybeabiomarkerandprognosticfactorinrenalcellcarcinomabybioinformaticsanalysis AT caohaoyuan interferoninducibleprotein16maybeabiomarkerandprognosticfactorinrenalcellcarcinomabybioinformaticsanalysis AT zhangfeilong interferoninducibleprotein16maybeabiomarkerandprognosticfactorinrenalcellcarcinomabybioinformaticsanalysis AT wangwei interferoninducibleprotein16maybeabiomarkerandprognosticfactorinrenalcellcarcinomabybioinformaticsanalysis |